Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus discovered in 1980. It is estimated that around 10–20 million people are infected …

ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

Human T-cell lymphoma virus (HTLV)-1 was the first human retrovirus to be discovered. It
has been recognized as the cause of adult T-cell leukemia (ATL). In addition to giving a …

HIV-1 is the most prevalent retrovirus, with over 30 million people infected worldwide.
Nevertheless, infection caused by other human retroviruses like HIV-2, HTLV-1, HTLV-2 …

So far, only two retroviruses, human immunodeficiency virus (HIV)(type 1 and 2) and human
T-cell lymphotropic virus type 1 (HTLV-1), have been recognized as pathogenic for humans …

The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Abstract HTLV-1 and HTLV-2 are highly related complex retroviruses that have been studied
intensely for nearly three decades because of their association with neoplasia …

Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered.
Studies on HTLV-1 have been instrumental for our understanding of the molecular …

Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that causes cancer (Adult T cell
Leukemia, ATL) and a spectrum of inflammatory diseases (mainly HTLV-associated …

The human retroviruses HIV-1 and HTLV-1/HTLV-2 share similar routes of transmission but
cause significantly different diseases. In this review we have outlined the immune mediated …